Programme

Monday 10th December 2018
The Royal College of Physicians, London, UK

Chairs:
Professor Derek Yellon
Professor of Molecular & Cellular Cardiology, University College London;
Director of the Hatter Cardiovascular Institute at UCL Hospitals & Medical School, London, UK

Professor John Cunningham
Professor of Nephrology, University College London Medical School and The Royal Free Hospital;
Honorary Fellowship, Trinity Hall, University of Cambridge, UK

Dr Richard Horton
Editor-in-Chief, The Lancet, London, UK


Please note that timings are provisional and subject to change.
Monday 10th December - Morning

From 08:30
Badge Collection & Coffee

09:30
Reducing the global burden of diabetes & cardiovascular disease: is there a role for governments?
Professor Dinky Levitt
University of Cape Town, South Africa

10:10
How will genetics impact on prevention and treatment of type 2 diabetes?
Professor Mark McCarthy
Oxford Centre for Diabetes, University of Oxford, UK

10:50
Coffee Break

11:15
The biology and therapeutic potential of GLP-1 - another year on!
Professor Daniel Drucker
University of Toronto, Canada

11:55
The biology and therapeutic potential of SGLT2 inhibition - another year on!
Professor Nikolaus Marx
University of Aachen, Germany

Monday 10th December - Afternoon

12:35
Lunch

13:30
SGLT2 Outcome trials - an evolving story
Professor Stephen Wiviott
Brigham & Women's Hospital, Boston, USA

14:10
Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes - i.e. weight management?
Professor Melanie Davies
Diabetes Research Centre, University of Leicester, UK

14:50
Is it time to rethink HbA1c?
Dr Dev Singh
New Cross Hospital, Wolverhampton, UK

15:30
Break

15:55
How do SGLT2 inhibitors benefit the kidney?
Professor David Wheeler
University College London

16:35
Is there still a place for sulphonylureas?
Professor Cliff Bailey
Aston University, Birmingham, UK

17:15
Close

 

Click here to register for the event

 

The meeting is supported by educational grants and sponsorship from the Pharmaceutical Industry. Supporters who have provided support for this programme have had no editorial control or influence of the content of the meeting.  Further information can be found here: https://horizonseries.org/hhs-2018/supporters/